Menu

Prime Medicine, Inc. PRME

Full chart Compare
Set alert

Price alert · PRME

All alert types
4.65 USD +0.20 (+4.49%)

At closeNov 6, 2026, 5:11 PM EST

4.65 0.00 0.00%

After hours · Nov 6, 5:11 PM ET

4.46 Day range 4.70
2.70 52-week range 5.36
YTD
+34.01%
1 year
+11.24%

Revenue & Expenses

Other Income → Expenses: $7.21MExpenses → Gross Loss: $2.69MExpenses → Selling, General & Admin: $52.35MExpenses → Research & Development: $160.64MOther Operating Income → Expenses: $7.32MNet Loss → Expenses: $201.14MRevenue → Cost of Revenue: $4.63MOther Income$7.21MOther Operating Income$7.32MNet Loss$201.14MCost of Revenue$7.32MExpenses$215.67MGross Loss$2.69MSelling, General & Admin$52.35MResearch & Development$160.64MRevenue$4.63M

Latest period ending Dec 31, 2025 · select a line to chart its full history

PRME annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.63M2.98M000
4.63M2.98M000
-208.35M-202.47M-204.79M-116.54M-84.47M
-201.14M-195.88M-198.13M-121.82M-165.37M
-1.35-1.65-2.18-4.19-14.19
PRME annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
76.72M196.54M55.07M201.12M198.54M
342.73M297.51M193.85M360.31M301.86M
221.87M144.36M60.78M44.04M62.30M
116.43M40.79M13.63M28.75M10.41M
120.87M153.15M133.07M316.27M-156.24M
PRME annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-162.56M-122.86M-165.41M-131.83M-34.08M
-108.76M68.46M18.71M-47.10M-73.63M
151.51M195.88M655.00K181.49M269.28M
-4.53M-7.29M-8.72M-16.09M-4.15M
-119.81M141.47M-146.05M2.57M161.57M